Cyclooxygenase-1 in human Alzheimer and control brain: Quantitative analysis of expression by microglia and CA3 hippocampal neurons

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 11, 1999, Pages 1135-1146

  Yermakova, Anna V ^a   Rollins, Jessica ^a   Callahan, Linda M ^a   Rogers, Joseph ^c   O'Banion, M Kerry ^a,b,d  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c SUN HEALTH RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Alzheimer disease; CNS; Hippocampus; Human; Microglia; Nonsteroidal anti inflammatory drugs; Prostaglandin endoperoxide synthase

Indexed keywords

CYCLOOXYGENASE 1; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACACA; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0032725481     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199911000-00003     Document Type: Article

References (89)

1. Rogers J, Webster S, Lue L-F, et al. Inflammation and Alzheimer's disease pathogenesis. Neurobiol Aging 1996;17:681-6
2. Rogers J, O'Barr S. Inflammatory mediators in Alzheimer's disease. In: Wasco W, Tanzi RE, eds. Molecular mechanisms of dementia. Totowa, NJ: Humana Press, Inc., 1997:177-98
3. McGeer P, McGeer E. The inflammation response system of the brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 1995;21:195-218
4. Aisen PS. Inflammation and Alzheimer disease. Mol Chem Neuropathol 1996;28:83-88
5. McGeer PL, McGeer EG. Anti-inflammatory drugs in the fight against Alzheimer's disease. Ann NY Acad Sci 1996;777:213-20
6. Rogers J. Inflammation as a pathogenic mechanism in Alzheimer's disease. Arzneimittel-Forschung 1995;45:439-42
7. Breitner JCS. Inflammatory processes and anti-inflammatory drugs in Alzheimer's disease: A current appraisal. Neurobiol Aging 1996;17:789-94
8. McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiological studies. Neurology 1996;47: 425-32
9. Stewart WF, Kawas C, Corrada M, Metter EJ. Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997;48:626-32
10. Rogers J, Kirby LC, Hempelman SR, et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology 1993;43:1609-11
11. Rich JB, Rasmusson DX, Folstein MF, Carson KA, Kawas C, Brandt J. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 1995;45:51-55
12. O'Banion MK, Sadowski HB, Winn V, Young DA. A serum-and glucocorticoid-regulated 4 kb mRNA encodes a cyclooxygenase related protein. J Biol Chem 1991;266:23261-67
13. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschmann HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991;266:12866-72
14. O'Banion MK, Winn VD, Young DA. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci USA 1992;89:4888-92
15. Pritchard KA, Jr., O'Banion MK, Miano JM, et al. Induction of cyclooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo. J Biol Chem 1994;269:8504-9
16. Masferrer JL, Zweifel BS, Manning PT, et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and non-ulcerogenic. Proc Natl Acad Sci USA 1994;91:3228-32
17. 2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med 1996;184:883-91
18. Vane JR, Botting RM. Mechanism of action of anti-inflammatory drugs. Scand J Rheumatol - Supplement 1996;102:9-21
19. Crofford LJ. COX-1 and COX-2 tissue expression: Implications and predictions. J Rheumatol 1997;24:15-19
20. O'Banion MK. Cyclooxygenase-2: Molecular biology, pharmacology, and neurobiology. Crit Rev Neurosci 1999;13:45-82
21. Nogawa S, Zhang F, Ross ME, Iadecola C. Cyclooxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 1997;17:2746-55
22. Nakayama M, Uchimura K, Zhu RL, et al. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc Natl Acad Sci USA 1998;95: 10954-59
23. McKanna JA, Zhang MZ. Immunohistochemical localization of lipocortin 1 in rat brain is sensitive to pH, freezing, and dehydration. J Histochem Cytochem 1997;45:527-38
24. O'Banion MK, Olschowka JA. Localization and distribution of cyclooxygenase-2 in brain tissue by immunocytochemistry. In: Lianos EA, ed. Prostaglandin protocols. Totowa, NJ: Humana Press Inc., Methods Mol Biol 1999;120:55-66
25. Thore CR, Nam MJ, Busija DW. Immunofluorescent localization of constitutive and inducible prostaglandin H synthase in ovine astroglia. J Comp Neurol 1996;367:1-9
26. Callahan LM, Selski DJ, Martzen MR, Cheetham JE, Coleman PD. Preliminary evidence: Decreased GAP-43 message in tangle-bearing neurons relative to adjacent tangle-free neurons in Alzheimer's disease parahippocampal gyrus. Neurobiol Aging 1994;15:381-86
27. Callahan LM, Vaules WA, Coleman PD. Quantitative decrease in synaptophysin message expression and increases in cathepsin D message expression in Alzheimer's neurons containing neurofibrillary tangles. J Neuropathol Exp Neurol 1999;58:275-87
28. Kaplan MD, Olschowka JA, O'Banion MK. Cyclooxygenase-1 behaves as a delayed response gene in PC12 cells differentiated by nerve growth factor. J Biol Chem 1997;272:18534-37
29. McGeer PL, Itagaki S, Hisao T, McGeer EG. Reactive microglia in patients with senile dementia of the Alzheimer's type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Let 1987;79:195-200
30. Rogers J, Luber-Narod J, Styren SD, Civin WH. Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease. Neurobiol Aging 1988;9:339-49
31. Styren SD, Civin WH, Rogers J. Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain. Exp Neurol 1990;110:93-104
32. Carpenter AF, Carpenter PW, Markesbery WR. Morphometric analysis of microglia in Alzheimer's disease. J Neuropathol Exp Neurol 1993;52:601-8
33. Mannoji H, Yeger H, Becker LE. A specific histochemical marker (lectin Ricinus communis agglutinin-1) for normal human microglia, and application to routine histopathology. Acta Neuropathol 1986;71:341-43
34. Mattiace LA, Davies P, Dickson DW. Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. Am J Pathol 1990;136:1101-14
35. O'Banion MK, Coleman PD, Callahan LM. Regional neuronal loss in aging and Alzheimer's disease: A brief review. Sem Neurosci 1994;6:307-14
36. Kaufmann WE, Andreasson KI, Isakson PC, Worley PF. Cyclooxygenases and the central nervous system. Prostaglandins 1997;54: 601-24
37. Breder CD. Cyclooxygenase systems in the mammalian brain. Ann NY Acad Sci 1997;813:296-301
38. Tsubokura S, Watanabe Y, Ehara H, et al. Localization of prostaglandin endoperoxide synthase in neurons and glia in monkey brain. Brain Res 1991;543:15-24
39. Breder CD, Smith WL, Raz A, et al. Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain. J Comp Neurol 1992;322:409-38
40. Kawasaki M, Yoshihara Y, Yamaji M, Watanabe Y. Expression of prostaglandin endoperoxide synthase in rat brain. Mol Brain Res 1993;19:39-46
41. Li S-R, Wu KK, Anggard E, Ferns G. Localization of prostaglandin G/H synthase gene expression in rat brain by in situ hybridization. Biol Signals 1994;2:77-83
42. Norton JL, Adamsom SL, Bocking AD, Han VKM. Prostaglandin-H synthase-1 (PGHS-1) gene is expressed in specific neurons of the brain of the late gestation ovine fetus. Dev Brain Res 1996;95: 79-96
43. Chang JW, Coleman PD, O'Banion MK. Prostaglandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease. Neurobiol Aging 1996;17:801-8
44. Kaufmann WE, Worley PF, Taylor CV, Bremer M, Isakson PC. Cyclooxygenase-2 expression during rat neocortical development and in Rett syndrome. Brain & Dev 1997;19:25-34
45. Yamagata K, Andreasson KI, Kaufmann WI, Barnes CA, Worley PF. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids. Neuron 1993;11:371-86
46. Tocco G, Freiremoar J, Schreiber SS, Sakhi SH, Aisen PS, Pasinetti GM. Maturational regulation and regional induction of cyclooxygenase-2 in rat brain - Implications for Alzheimer's disease. Exp Neurol 1997;144:339-49
47. Breder CD, DeWitt D, Kraig RP. Characterization of inducible cyclooxygenase in rat brain. J Comp Neurol 1995;355:296-315
48. Kaufmann WE, Worley PF, Pegg J, Bremer M, Isakson P. Cox-2, a synaptically-induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci USA 1996;93:2317-21
49. Bazan NG, Birkle DL, Tang W, Reddy TS. The accumulation of free arachidonic acid, diacylglycerols, prostaglandins, and lipoxygenase reaction products in the brain during experimental epilepsy. Adv Neurol 1986;44:879-902
50. Adams J, Collaço-Moraes Y, de Belleroche J. Cyclooxygenase-2 induction in cerebral cortex: An intracellular response to synaptic excitation. J Neurochem 1996;66:6-13
51. Chen J, Marsh T, Zhang JS, Graham SH. Expression of cyclooxygenase-2 in rat brain following kainate treatment. Neuroreport 1995;6:245-48
52. Marcheselli VL, Bazan NG. Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. J Biol Chem 1996;271:24794-99
53. Lerea LS, McNamara JO. Ionotropic glutamate receptor subtypes activate c-fos transcription by distinct calcium requiring intracellular pathways. Neuron 1993;10:31-41
54. 2α is required for NMDA receptor-mediated induction of c-fos mRNA in dentate gyrus neurons. J Neurosci 1997;17:117-24
55. 2-requiring intracellular signaling pathways. Mol Pharmacol 1995;47:1119-25
56. Nogawa S, Forster C, Zhang F, Nagayama M, Ross ME, Iadecola C. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci USA 1998;95:10966-71
57. West MJ, Coleman PD, Flood DG, Troncoso JD. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 1994;344:769-72
58. Pasinetti GM, Aisen PS. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 1998;87:319-24
59. Minghetti L, Levi G. Microglia as effector cells in brain damage and repair: Focus on prostanoids and nitric oxide. Prog Neurobiol 1997;54:99-125
60. Minghetti L, Levi G. Induction of prostanoid biosynthesis by bacterial lipopolysaccharide and isoproterenol in rat microglial cultures. J Neurochem 1995;65:2690-98
61. Slepko N, Minghetti L, Polazzi E, Nicolini A, Levi G. Reorientation of prostanoid production accompanies "activation" of adult microglial cells in culture. J Neurosci Res 1997;49:292-300
62. 2. Proc Natl Acad Sci USA 1997;94:6500-505
63. Dickson DW, Lee SC, Mattiace LA, Yen S-HC, Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 1993;7:75-83
64. Kreutzberg GW. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 1996;19:312-18
65. Haga S, Akai K, Ishii T. Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain: An immunohistochemical study using a novel monoclonal antibody. Acta Neuropathol 1989;77:569-75
66. Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 1989;24:173-82
67. Uchihara T, Akiyama H, Kondo H, Ikeda K. Activated microglial cells are colocalized with perivascular deposits of amyloid-beta protein in Alzheimer's disease brain. Stroke 1997;28:1948-50
68. Cotman CW, Tenner AJ, Cummings BJ. β-amyloid converts an acute phase injury response to chronic injury reponses. Neurobiol Aging 1996;17:723-31
69. Mackenzie IRA, Hao C, Munoz DG. Role of microglia in senile plaque formation. Neurobiol Aging 1995;16:797-804
70. Uchihara T, Kondo H, Akiyama H, Ikeda K. White matter amyloid in Alzheimer's disease brain. Acta Neuropathologica 1995;90: 51-56
71. Ohgami T, Kitamoto T, Shin RW, Kaneko Y, Ogomori K, Tateishi J. Increased senile plaques without microglia in Alzheimer's disease. Acta Neuropathologica 1991;81:242-47
72. Cras P, Kawai M, Siedlak S, et al. Neuronal and microglial involvement in beta amyloid protein deposition in Alzheimer's disease. Am J Pathol 1990;137:241-46
73. Haass C, Hung AY, Selkoe DJ. Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion. J Neurosci 1991;11:3783-93
74. Bauer J, Konig G, Strauss S, et al. In-vitro matured human macrophages express Alzheimer's beta A4-amyloid precursor protein indicating synthesis in microglial cells. FEBS Letters 1991;282: 335-40
75. Shigematsu K, McGeer PL. Accumulation of amyloid precursor protein in damaged neuronal processes and microglia following intracerebral administration of aluminum salts. Brain Res 1992;593: 117-23
76. Meda L, Cassatella MA, Szendrei GI, et al. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 1995;374:647-50
77. McDonald DR, Bamberger ME, Combs CK, Landreth GE. beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J Neurosci 1998;18: 4451-60
78. Dickson DW. The pathogenesis of senile plaques. J Neuropathol Exp Neurol 1997;56:321-39
79. Barger SW, Harmon AD. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 1997;388:878-81
80. Griffin WST, Sheng JG, Mrak RE. Inflammatory pathways: Implications in Alzheimer's disease. In Wasco W, Tanzi RE, eds. Molecular mechanisms of dementia. Totowa, NJ: Humana Press, Inc., 1997:169-76
81. Frautschy SA, Yang F, Irrizarry M, et al. Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol 1998;152: 307-17
82. Netland EE, Newton JL, Majocha RE, Tate BA. Indomethacin reverses the microglial response to amyloid beta-protein. Neurobiol Aging 1998;19:201-4
83. Mackenzie IRA, Munoz DG. Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. Neurology 1998;50: 986-90
84. Kitamura Y, Shimohama S, Koike H, et al. Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-γ in Alzheimer's disease brains. Biochem Biophys Res Comm 1999;254:582-86
85. 2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol Dis 1996;3:51-63
86. Lehtonen JY, Holopainen JM, Kinnunen PK. Activation of phospholipase A2 by amyloid beta-peptides in vitro. Biochemistry 1996;35:9407-14
87. Iwamoto N, Kobayashi K, Kosaka K. The formation of prostaglandins in the postmortem cerebral cortex of Alzheimer-type dementia patients. J Neurol 1989;236:80-84
88. Wong PT, McGeer PL, McGeer EG. Decreased prostaglandin synthesis in postmortem cerebral cortex from patient's with Alzheimer's disease. Neurochem Int 1992;21:197-202
89. Giulian D, Corpuz M, Richmond B, Wendt E, Hall ER. Activated microglia are the principal glial source of thromboxane in the central nervous system. Neurochem Int 1996;29:65-76